THE MEDUCOM POST

October 28, 2016

Just a few weeks after the European Society of Medical Oncology (ESMO) Conference wrapped up in Denmark, the U.S. FDA has approved Keytruda (pembrolizumab) for first-line use. KEYNOTE-024 was presented at ESMO.

The trial showed a significant improvement in progression-...

Please reload

Archives

Please reload

Please reload

Recent Posts

July 28, 2020

Please reload

  • Black Twitter Icon
  • Black LinkedIn Icon